ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 76 filers reported holding ARCUS BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $780,646 | -31.5% | 43,490 | -22.5% | 0.00% | 0.0% |
Q2 2023 | $1,140,366 | +80.7% | 56,148 | +62.3% | 0.00% | 0.0% |
Q1 2023 | $630,976 | -18.6% | 34,593 | -7.7% | 0.00% | 0.0% |
Q4 2022 | $775,065 | -24.1% | 37,479 | -3.9% | 0.00% | 0.0% |
Q3 2022 | $1,021,000 | +36.9% | 38,985 | +32.5% | 0.00% | 0.0% |
Q2 2022 | $746,000 | -26.3% | 29,433 | -8.2% | 0.00% | 0.0% |
Q1 2022 | $1,012,000 | -26.0% | 32,061 | -5.1% | 0.00% | 0.0% |
Q4 2021 | $1,367,000 | +18.7% | 33,784 | +2.2% | 0.00% | 0.0% |
Q3 2021 | $1,152,000 | +38.1% | 33,055 | +8.1% | 0.00% | – |
Q2 2021 | $834,000 | -8.3% | 30,568 | -5.6% | 0.00% | – |
Q1 2021 | $909,000 | -45.8% | 32,370 | -49.9% | 0.00% | -100.0% |
Q4 2020 | $1,676,000 | -4.8% | 64,557 | -37.1% | 0.00% | 0.0% |
Q3 2020 | $1,760,000 | +7.4% | 102,687 | +55.1% | 0.00% | 0.0% |
Q2 2020 | $1,638,000 | +695.1% | 66,194 | +348.3% | 0.00% | – |
Q1 2020 | $206,000 | +79.1% | 14,767 | +29.3% | 0.00% | – |
Q4 2019 | $115,000 | -26.8% | 11,422 | -33.8% | 0.00% | – |
Q3 2019 | $157,000 | +28.7% | 17,264 | +12.2% | 0.00% | – |
Q2 2019 | $122,000 | -46.3% | 15,387 | -15.6% | 0.00% | – |
Q1 2019 | $227,000 | +58.7% | 18,225 | +37.8% | 0.00% | – |
Q4 2018 | $143,000 | – | 13,229 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |